Concurrent proton-pump inhibitors increase risk of death...

Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study

Fang, Yu-Hung, Yang, Yao-Hsu, Hsieh, Meng-Jer, Hung, Ming-Szu, Lin, Yu-Ching
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 11
Language:
english
Journal:
Cancer Management and Research
DOI:
10.2147/CMAR.S222278
Date:
September, 2019
File:
PDF, 1.97 MB
english, 2019
Conversion to is in progress
Conversion to is failed